← Back to Knowledge Base

Primary topic: APOE gene metabolism

APOE Gene and Metabolism: What It Means for Your Body

APOE is important for lipid transport and how fats are packaged and moved through the body, making it relevant to cholesterol and metabolic resilience.

What is the APOE gene?

APOE helps transport lipids and cholesterol between tissues. Because fat transport is central to cellular structure, energy use, and lipoprotein balance, APOE can influence how cleanly lipid metabolism runs under ordinary conditions.

How APOE affects metabolism

When APOE-related transport is less efficient, lipid handling may require more attention. That can matter for cholesterol patterns, response to dietary fat, and how well lipid-related signals stay within healthy ranges.

What happens when APOE is altered

Altered APOE signaling does not automatically mean poor metabolic health, but it can shift how aggressively lipid balance should be monitored and how useful personalized follow-up may be compared with generic advice.

Curated SNP evidence for APOE

These SNPs come from the approved study-level evidence model. Each claim is scored from curated study rows, then gated before it can influence pathway scoring.

Lipids

Evidence-backed report connection

APOE currently has 2 curated SNPs, 6 claim-level scores, and 4 claims eligible for pathway scoring.

Open the sample report
rs429358APOE defining SNP3 claims · 9 study rows

biomarker tendency · CC

APOE biomarker tendency

Strong

rs429358 CC is associated with increased APOE biomarker tendency.

APOE rs429358 is scored as a cautious APOE biomarker-component tendency for C-containing genotypes, strongest for CC.

Likely effectHigher biomarker tendency
Signal sizeSmall signal
Evidence supportStrong support
Report useIncluded in pathway scoring
Show study evidence
NCBI RefSNP recordidentity only · unknownNCBI RefSNP data place rs429358 in APOE and report T and C alleles for this variant. This supports the CC, CT, and TT genotype letters used in the simplified record.PMC5127235biomarker association · close proxyThe Diabetes Heart Study MIND paper describes APOE haplotype status as determined from rs429358 and rs7412, and identifies rs429358 as a coding variant that helps define the apoE protein isoforms E2, E3, and E4. This supports scoring rs429358 as an APOE biomarker component rather than as a stand-alone diagnosis.PMC4182517biomarker association · close proxyTejedor et al. reported that rs429358 and rs7412 together give rise to common APOE haplotypes and that these APOE polymorphisms are strongly associated with variation in plasma cholesterol and triglycerides. In that cohort, rs429358 alone was not associated with body-mass or waist measures after adjustment, supporting conservative interpretation.

biomarker tendency · CT

APOE biomarker tendency

Moderate

rs429358 CT is associated with increased APOE biomarker tendency.

APOE rs429358 is scored as a cautious APOE biomarker-component tendency for C-containing genotypes, strongest for CC.

Likely effectHigher biomarker tendency
Signal sizeSmall signal
Evidence supportModerate support
Report useIncluded in pathway scoring
Show study evidence
NCBI RefSNP recordidentity only · unknownNCBI RefSNP data place rs429358 in APOE and report T and C alleles for this variant. This supports the CC, CT, and TT genotype letters used in the simplified record.PMC5127235biomarker association · close proxyThe Diabetes Heart Study MIND paper describes APOE haplotype status as determined from rs429358 and rs7412, and identifies rs429358 as a coding variant that helps define the apoE protein isoforms E2, E3, and E4. This supports scoring rs429358 as an APOE biomarker component rather than as a stand-alone diagnosis.PMC4182517biomarker association · close proxyTejedor et al. reported that rs429358 and rs7412 together give rise to common APOE haplotypes and that these APOE polymorphisms are strongly associated with variation in plasma cholesterol and triglycerides. In that cohort, rs429358 alone was not associated with body-mass or waist measures after adjustment, supporting conservative interpretation.

biomarker tendency · TT

APOE biomarker tendency

Not used for pathway scoring

rs429358 TT has no scored directional claim for APOE biomarker tendency.

APOE rs429358 is scored as a cautious APOE biomarker-component tendency for C-containing genotypes, strongest for CC.

Likely effectNo clear biomarker tendency
Signal sizeMinimal signal
Evidence supportVery limited support
Report useEvidence only, not scored
Show study evidence
NCBI RefSNP recordidentity only · unknownNCBI RefSNP data place rs429358 in APOE and report T and C alleles for this variant. This supports the CC, CT, and TT genotype letters used in the simplified record.PMC5127235biomarker association · close proxyThe Diabetes Heart Study MIND paper describes APOE haplotype status as determined from rs429358 and rs7412, and identifies rs429358 as a coding variant that helps define the apoE protein isoforms E2, E3, and E4. This supports scoring rs429358 as an APOE biomarker component rather than as a stand-alone diagnosis.PMC4182517biomarker association · close proxyTejedor et al. reported that rs429358 and rs7412 together give rise to common APOE haplotypes and that these APOE polymorphisms are strongly associated with variation in plasma cholesterol and triglycerides. In that cohort, rs429358 alone was not associated with body-mass or waist measures after adjustment, supporting conservative interpretation.
rs7412APOE defining SNP3 claims · 9 study rows

biomarker tendency · TT

APOE biomarker tendency

Moderate

rs7412 TT is associated with reduced APOE biomarker tendency.

APOE rs7412 is scored as a cautious lower-LDL/APOE2-component biomarker tendency for T-containing genotypes, strongest for TT.

Likely effectLower biomarker tendency
Signal sizeSmall signal
Evidence supportModerate support
Report useIncluded in pathway scoring
Show study evidence
NCBI RefSNP recordidentity only · unknownNCBI RefSNP data place rs7412 in APOE and report C and T alleles for this variant. This supports the CC, CT, and TT genotype letters used in the simplified record.PMC5127235biomarker association · loose proxyThe Diabetes Heart Study MIND paper describes APOE haplotype status as determined from rs429358 and rs7412, and identifies rs7412 as a coding variant that helps define the apoE protein isoforms E2, E3, and E4. The same paper reported lower LDL cholesterol in the APOE E2 haplotype group in European Americans with type 2 diabetes, with a similar trend in African Americans.PMC4182517biomarker association · close proxyTejedor et al. reported that rs429358 and rs7412 together give rise to common APOE haplotypes and that these APOE polymorphisms are strongly associated with plasma cholesterol and triglyceride variation. The study also reported rs7412 associations with body-mass and waist measures in middle-aged men, supporting trait-specific caveats rather than a broad health claim.

biomarker tendency · CT

APOE biomarker tendency

Moderate

rs7412 CT is associated with reduced APOE biomarker tendency.

APOE rs7412 is scored as a cautious lower-LDL/APOE2-component biomarker tendency for T-containing genotypes, strongest for TT.

Likely effectLower biomarker tendency
Signal sizeSmall signal
Evidence supportModerate support
Report useIncluded in pathway scoring
Show study evidence
NCBI RefSNP recordidentity only · unknownNCBI RefSNP data place rs7412 in APOE and report C and T alleles for this variant. This supports the CC, CT, and TT genotype letters used in the simplified record.PMC5127235biomarker association · loose proxyThe Diabetes Heart Study MIND paper describes APOE haplotype status as determined from rs429358 and rs7412, and identifies rs7412 as a coding variant that helps define the apoE protein isoforms E2, E3, and E4. The same paper reported lower LDL cholesterol in the APOE E2 haplotype group in European Americans with type 2 diabetes, with a similar trend in African Americans.PMC4182517biomarker association · close proxyTejedor et al. reported that rs429358 and rs7412 together give rise to common APOE haplotypes and that these APOE polymorphisms are strongly associated with plasma cholesterol and triglyceride variation. The study also reported rs7412 associations with body-mass and waist measures in middle-aged men, supporting trait-specific caveats rather than a broad health claim.

biomarker tendency · CC

APOE biomarker tendency

Not used for pathway scoring

rs7412 CC has no scored directional claim for APOE biomarker tendency.

APOE rs7412 is scored as a cautious lower-LDL/APOE2-component biomarker tendency for T-containing genotypes, strongest for TT.

Likely effectNo clear biomarker tendency
Signal sizeMinimal signal
Evidence supportVery limited support
Report useEvidence only, not scored
Show study evidence
NCBI RefSNP recordidentity only · unknownNCBI RefSNP data place rs7412 in APOE and report C and T alleles for this variant. This supports the CC, CT, and TT genotype letters used in the simplified record.PMC5127235biomarker association · loose proxyThe Diabetes Heart Study MIND paper describes APOE haplotype status as determined from rs429358 and rs7412, and identifies rs7412 as a coding variant that helps define the apoE protein isoforms E2, E3, and E4. The same paper reported lower LDL cholesterol in the APOE E2 haplotype group in European Americans with type 2 diabetes, with a similar trend in African Americans.PMC4182517biomarker association · close proxyTejedor et al. reported that rs429358 and rs7412 together give rise to common APOE haplotypes and that these APOE polymorphisms are strongly associated with plasma cholesterol and triglyceride variation. The study also reported rs7412 associations with body-mass and waist measures in middle-aged men, supporting trait-specific caveats rather than a broad health claim.

Common symptoms people report

  • concern about cholesterol despite reasonable habits
  • variable response to higher-fat diets
  • family context around lipid issues
  • uncertainty about which fat-related markers matter most

Biomarkers to validate

ApoB

Useful for understanding particle-related lipid risk more clearly than total cholesterol alone.

LDL-C and non-HDL cholesterol

Adds direct context for lipid transport outcomes.

Triglycerides

Helps assess broader lipid-handling efficiency.

Where DNA analysis helps

DNA can show whether lipid-transport pathways deserve more focused monitoring than standard wellness advice provides. The goal is to prioritize meaningful markers, not to overread one gene in isolation.

Example Insight

Your lipid-transport pathway may deserve more structured monitoring than generic nutrition advice usually provides.

Suggested validation: apoB and triglycerides.

What to do next

  • Use APOE as a prompt to validate lipid markers rather than to assume a fixed outcome.
  • Check apoB and triglycerides when dietary fat response seems unclear.
  • Compare APOE with PPARA and PPARG when fat-metabolism questions overlap.

Upload your DNA file and receive a structured metabolic pathway analysis with prioritized insights and suggested validation markers.

Get My DNA Report

Related pages

FTO

FTO gene weight gain

PEMT

PEMT gene choline metabolism

Triglycerides

triglycerides and metabolic health

ApoB

ApoB and lipid risk

Glucose regulation pathway

glucose regulation pathway

Lipid transport pathway

lipid transport pathway

Upload DNA for health report

upload DNA for health report

Related symptom angle

Slow metabolism genetics

Browse the knowledge base

See the full index of gene guides, biomarker guides, pathway guides, symptoms, buyer pages, and common questions.